June 15, 2012 — CardiAQ Valve Technologies (CardiAQ), which has developed the world’s first self-conforming and self-anchoring technology for nonsurgical transcatheter mitral valve implantation (TMVI), today announced that the company has achieved a cardiovascular medicine milestone: a bioprosthetic mitral heart valve was successfully implanted as a compassionate treatment into an 86-year-old male suffering from severe mitral regurgitation (MR 4+).

June 15, 2012 — At the Society of Nuclear Medicine’s (SNM) 59th Annual Meeting in Miami Beach, Fla., June 9-12, Cardinal Health introduced new technology enhancements that make it possible for hospital nuclear medicine departments and imaging centers to seamlessly improve data integration and the overall efficiency of their operations.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now